Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pohlmann

Showing results (241-250 of 261) with videos related to

Pageof 27
Sort By:
Breast Cancer Research and Treatment|March 11, 2019
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt studyF Lynce, A Barac, X Geng, et al.
Cancer Research Communications|August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 UnitCamila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
JAMIA Open|February 7, 2020
A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patientsMichael J Pishvaian, Edik M Blais, R Joseph Bender, et al.
Cancer Research|March 3, 2017
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerValerie M Jansen, Neil E Bhola, Joshua A Bauer, et al.
Cancer Research|February 17, 2019
Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerValerie M Jansen, Neil E Bhola, Joshua A Bauer, et al.
Discover Nano|November 14, 2024
Effects of nanocapsules containing lumefantrine and artemether in an experimental model of cerebral malariaBianca Portugal Tavares de Moraes, Karoline Paiva da Silva, Karina Paese, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Nature Communications|December 9, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumorsMark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf, et al.
The Oncologist|March 14, 2026
Telemedicine as a Gateway to Early-Phase Oncology Trials: Lessons from 14,000 Patients and Future Directions for Global Access and EquityCarlos Torrado, Clark R Andersen, Lei Kang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 24, 2026
DHA-loaded nanocapsules enhance microcirculation and reduce inflammation in sepsis experimental modelBianca Portugal Tavares de Moraes, Karoline Paiva da Silva, Isabelle de Moraes-de-Souza, et al.
Pageof 27

Showing results (241-250 of 261) with videos related to

Sort By:
Pageof 27
Breast Cancer Research and Treatment|March 11, 2019
Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt studyF Lynce, A Barac, X Geng, et al.
Cancer Research Communications|August 27, 2025
Modulating Treatment Outcomes of Patients with Solid Tumors in Immunotherapy Trials: A Drug Interaction Analysis from a Phase 1 UnitCamila Braganca Xavier, Clark R Andersen, JoAnn Lim, et al.
JAMIA Open|February 7, 2020
A virtual molecular tumor board to improve efficiency and scalability of delivering precision oncology to physicians and their patientsMichael J Pishvaian, Edik M Blais, R Joseph Bender, et al.
Cancer Research|March 3, 2017
Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerValerie M Jansen, Neil E Bhola, Joshua A Bauer, et al.
Cancer Research|February 17, 2019
Correction: Kinome-Wide RNA Interference Screen Reveals a Role for PDK1 in Acquired Resistance to CDK4/6 Inhibition in ER-Positive Breast CancerValerie M Jansen, Neil E Bhola, Joshua A Bauer, et al.
Discover Nano|November 14, 2024
Effects of nanocapsules containing lumefantrine and artemether in an experimental model of cerebral malariaBianca Portugal Tavares de Moraes, Karoline Paiva da Silva, Karina Paese, et al.
Nature Medicine|February 7, 2025
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trialKim A Reiss, Mathew G Angelos, E Claire Dees, et al.
Nature Communications|December 9, 2025
Circulating tumor DNA refines risk stratification of neoadjuvant therapy-resistant breast tumorsMark Jesus M Magbanua, Nayelis A Manon, Denise M Wolf, et al.
The Oncologist|March 14, 2026
Telemedicine as a Gateway to Early-Phase Oncology Trials: Lessons from 14,000 Patients and Future Directions for Global Access and EquityCarlos Torrado, Clark R Andersen, Lei Kang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 24, 2026
DHA-loaded nanocapsules enhance microcirculation and reduce inflammation in sepsis experimental modelBianca Portugal Tavares de Moraes, Karoline Paiva da Silva, Isabelle de Moraes-de-Souza, et al.
Pageof 27